Proteonomix Bets On Dubai For Stem-cell Products
This article was originally published in PharmAsia News
Executive Summary
New Jersey-based biotech Proteonomix is betting big on emerging markets as the next frontier for its cell technology products; the company is about to commence operation of its Dubai joint venture XGen Medical as a launch pad for the region